BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38129099)

  • 1. Expanding association between BICD2 variants and brain malformations and associated lissencephaly.
    Cho J; Kim H; Lee S; Yoon JG; Kim H; Kim M; Jang S; Kim W; Kim SY; Chae JH
    Clin Exp Pediatr; 2024 Jan; 67(1):54-56. PubMed ID: 38129099
    [No Abstract]   [Full Text] [Related]  

  • 2. Impairment in dynein-mediated nuclear translocation by BICD2 C-terminal truncation leads to neuronal migration defect and human brain malformation.
    Tsai MH; Cheng HY; Nian FS; Liu C; Chao NH; Chiang KL; Chen SF; Tsai JW
    Acta Neuropathol Commun; 2020 Jul; 8(1):106. PubMed ID: 32665036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted re-sequencing in malformations of cortical development: genotype-phenotype correlations.
    Accogli A; Severino M; Riva A; Madia F; Balagura G; Iacomino M; Carlini B; Baldassari S; Giacomini T; Croci C; Pisciotta L; Messana T; Boni A; Russo A; Bilo L; Tonziello R; Coppola A; Filla A; Mecarelli O; Casalone R; Pisani F; Falsaperla R; Marino S; Parisi P; Ferretti A; Elia M; Luchetti A; Milani D; Vanadia F; Silvestri L; Rebessi E; Parente E; Vatti G; Mancardi MM; Nobili L; Capra V; Salpietro V; Striano P; Zara F
    Seizure; 2020 Aug; 80():145-152. PubMed ID: 32570172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bi-allelic Pathogenic Variants in TUBGCP2 Cause Microcephaly and Lissencephaly Spectrum Disorders.
    Mitani T; Punetha J; Akalin I; Pehlivan D; Dawidziuk M; Coban Akdemir Z; Yilmaz S; Aslan E; Hunter JV; Hijazi H; Grochowski CM; Jhangiani SN; Karaca E; Fatih JM; Iwanowski P; Gambin T; Wlasienko P; Goszczanska-Ciuchta A; Bekiesinska-Figatowska M; Hosseini M; Arzhangi S; Najmabadi H; Rosenfeld JA; Du H; Marafi D; Blaser S; Teitelbaum R; Silver R; ; Posey JE; Ropers HH; Gibbs RA; Wiszniewski W; Lupski JR; Chitayat D; Kahrizi K; Gawlinski P
    Am J Hum Genet; 2019 Nov; 105(5):1005-1015. PubMed ID: 31630790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model of lissencephaly: expanding the role of DCX during neurogenesis.
    Shahsavani M; Pronk RJ; Falk R; Lam M; Moslem M; Linker SB; Salma J; Day K; Schuster J; Anderlid BM; Dahl N; Gage FH; Falk A
    Mol Psychiatry; 2018 Jul; 23(7):1674-1684. PubMed ID: 28924182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic and clinical aspects of lissencephaly].
    Verloes A; Elmaleh M; Gonzales M; Laquerrière A; Gressens P
    Rev Neurol (Paris); 2007 May; 163(5):533-47. PubMed ID: 17571022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular Atrophy.
    Koboldt DC; Waldrop MA; Wilson RK; Flanigan KM
    Ann Neurol; 2020 Apr; 87(4):487-496. PubMed ID: 32057122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lissencephaly-associated DCX variants in the C-terminal DCX domain affect microtubule binding and dynamics.
    Lin JR; Cheng JF; Liu YT; Hsu TR; Lin KM; Chen C; Lin CL; Tsai MH; Tsai JW
    Epilepsia; 2022 May; 63(5):1253-1265. PubMed ID: 35213059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the phenotype of BICD2 mutations toward skeletal muscle involvement.
    Unger A; Dekomien G; Güttsches A; Dreps T; Kley R; Tegenthoff M; Ferbert A; Weis J; Heyer C; Linke WA; Martinez-Carrera L; Storbeck M; Wirth B; Hoffjan S; Vorgerd M
    Neurology; 2016 Nov; 87(21):2235-2243. PubMed ID: 27784775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lissencephalic syndromes: brain and beyond.
    Pavone L; Corsello G; Pavone P; Iannetti P
    Front Biosci (Schol Ed); 2010 Jan; 2(1):85-95. PubMed ID: 20036930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy.
    Neveling K; Martinez-Carrera LA; Hölker I; Heister A; Verrips A; Hosseini-Barkooie SM; Gilissen C; Vermeer S; Pennings M; Meijer R; te Riele M; Frijns CJ; Suchowersky O; MacLaren L; Rudnik-Schöneborn S; Sinke RJ; Zerres K; Lowry RB; Lemmink HH; Garbes L; Veltman JA; Schelhaas HJ; Scheffer H; Wirth B
    Am J Hum Genet; 2013 Jun; 92(6):946-54. PubMed ID: 23664116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic and Biochemical Hallmarks of
    Unger A; Roos A; Gangfuß A; Hentschel A; Gläser D; Krause K; Doering K; Schara-Schmidt U; Hoffjan S; Vorgerd M; Güttsches AK
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047781
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo.
    Will L; Portegies S; van Schelt J; van Luyk M; Jaarsma D; Hoogenraad CC
    Acta Neuropathol Commun; 2019 Oct; 7(1):162. PubMed ID: 31655624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Names of Things: The 2018 Bernard Sachs Lecture.
    Dobyns WB
    Pediatr Neurol; 2021 Sep; 122():41-49. PubMed ID: 34330614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Diagnosis of Lissencephaly Associated with Biallelic Pathologic Variants in the COQ2 Gene.
    Rosado Santos R; Rodrigues M; Loureiro T
    Acta Med Port; 2023 Jun; 36(6):428-431. PubMed ID: 36168972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy.
    Rossor AM; Sleigh JN; Groves M; Muntoni F; Reilly MM; Hoogenraad CC; Schiavo G
    Acta Neuropathol Commun; 2020 Mar; 8(1):34. PubMed ID: 32183910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy.
    Luo K; Zheng C; Luo R; Cao X; Sun H; Ma H; Huang J; Yang X; Wu X; Li X
    BMC Med Genomics; 2022 Sep; 15(1):189. PubMed ID: 36068540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent de novo BICD2 mutation associated with arthrogryposis multiplex congenita and bilateral perisylvian polymicrogyria.
    Ravenscroft G; Di Donato N; Hahn G; Davis MR; Craven PD; Poke G; Neas KR; Neuhann TM; Dobyns WB; Laing NG
    Neuromuscul Disord; 2016 Nov; 26(11):744-748. PubMed ID: 27751653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic extremes of BICD2-opathies: from lethal, congenital muscular atrophy with arthrogryposis to asymptomatic with subclinical features.
    Storbeck M; Horsberg Eriksen B; Unger A; Hölker I; Aukrust I; Martínez-Carrera LA; Linke WA; Ferbert A; Heller R; Vorgerd M; Houge G; Wirth B
    Eur J Hum Genet; 2017 Sep; 25(9):1040-1048. PubMed ID: 28635954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Likely pathogenic variant in the BICD2 gene in fetus presenting with non-immune hydrops.
    Chandler N; Brace P; Roberts R; Mellis R
    Prenat Diagn; 2023 Jun; 43(6):727-729. PubMed ID: 37173812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.